SP Accure Labs Private Limited — Paclitaxel Exporter Profile
Indian Pharmaceutical Exporter · #13 for Paclitaxel · $1.3M export value · DGFT Verified
SP Accure Labs Private Limited is the #13 Indian exporter of Paclitaxel with $1.3M in export value and 66 verified shipments. SP Accure Labs Private Limited holds a 1.5% market share in Paclitaxel exports across 9 countries. The company exports 14 pharmaceutical products worth $3.5M across 3 therapeutic categories.
SP Accure Labs Private Limited — Paclitaxel Export Profile: Buyers & Destinations

Where Does SP Accure Labs Private Limited Export Paclitaxel?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOROCCO | $396.8K | 17 | 37.8% |
| NEPAL | $251.3K | 26 | 24.0% |
| LEBANON | $179.3K | 9 | 17.1% |
| PERU | $141.0K | 8 | 13.5% |
| COLOMBIA | $50.0K | 1 | 4.8% |
| GUYANA | $17.4K | 1 | 1.7% |
| GAUTEMALA | $10.5K | 2 | 1.0% |
| CAMBODIA | $2.2K | 1 | 0.2% |
| BELARUS | $5 | 4 | 0.0% |
SP Accure Labs Private Limited exports Paclitaxel to 9 countries. The largest destination is MOROCCO accounting for 37.8% of SP Accure Labs Private Limited's Paclitaxel shipments, followed by NEPAL (24.0%) and LEBANON (17.1%). These destinations reflect SP Accure Labs Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Paclitaxel from SP Accure Labs Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BOTTU S.A | MOROCCO | $189.1K | 11 |
| BOTTU S A | MOROCCO | $154.3K | 4 |
| G.F.T.O/NORSEN LEBANON | LEBANON | $97.2K | 4 |
| CENTRO NACIONAL DE ABASTECIMIENTO D | PERU | $90.6K | 5 |
| NORSEN LEBANON | LEBANON | $56.5K | 3 |
| MEDFIELDS TRADING MIDDLE EAST | MOROCCO | $53.4K | 2 |
| TAJ NEPAL PRIVATE LIMITED | NEPAL | $51.1K | 5 |
| NEXT PHARMA SURCING SAS | COLOMBIA | $50.0K | 1 |
| TAJ NEPAL PVT L T D | NEPAL | $47.5K | 6 |
| TAJ ONCOTHERAPY PVT. LTD. | NEPAL | $46.4K | 2 |
SP Accure Labs Private Limited supplies Paclitaxel to 23 buyers globally. The largest buyer is BOTTU S.A (MOROCCO), followed by BOTTU S A (MOROCCO) and G.F.T.O/NORSEN LEBANON (LEBANON). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Paclitaxel Export Value and How Much Does SP Accure Labs Private Limited Contribute?
India exported $61.4M worth of Paclitaxel through 4,928 shipments from 319 suppliers to 142 countries, serving 959 buyers globally. SP Accure Labs Private Limited contributes $1.3M to this total, accounting for 1.5% of India's Paclitaxel exports. SP Accure Labs Private Limited ships Paclitaxel to 9 countries through 23 buyers.
What Is the Average Shipment Value for SP Accure Labs Private Limited's Paclitaxel Exports?
SP Accure Labs Private Limited's average Paclitaxel shipment value is $19.0K per consignment, based on 66 shipments totaling $1.3M. The largest destination is MOROCCO (37.8% of SP Accure Labs Private Limited's Paclitaxel exports).
How Does SP Accure Labs Private Limited Compare to Other Indian Paclitaxel Exporters?
SP Accure Labs Private Limited ranks #13 among 319 Indian Paclitaxel exporters with a 1.5% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($25.1M), MSN LABORATORIES PRIVATE LIMITED ($6.9M), INTAS PHARMACEUTICALS LIMITED ($5.9M). SP Accure Labs Private Limited processed 66 shipments to 9 destination countries.
What Paclitaxel Formulations Does SP Accure Labs Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PACLI SPAL L 300 Paclitaxel ConcentrateforSolution for Infusion USP 300mg 50mL | $104.3K | 3 |
| PACLI SPAL-L 300 (PACLITAXEL CONCENTRATEFOR SOLUTION FOR INFUSION USP 300MG/50ML) | $102.3K | 3 |
| PACLI SPAL-L 100 (PACLITAXEL INJECTION 1 | $69.8K | 4 |
| PALIT SPAL 100(PACLITAXEL PROTEIN BOUNDPARTICLES FOR INJECTABLE SUSPENSION 100MG)NOS | $53.5K | 2 |
| PACLITAXEL CONCENTRATE FOR SOLUTION FORINFUSION USP 30MG 5ML BATCH NO 25EPL02 MFG 05 2025 EXP 04 2028 AS PER INV | $53.4K | 2 |
| PACLI SPAL 300 (PACLITAXEL INJECTION IP3 | $50.0K | 1 |
| PACLI SPAL L 300 Paclitaxel ConcentrateforSolution for Infusion USP300mg 50mL | $50.0K | 1 |
| PACLI SPAL 300 (PACLITAXEL CONCENTRATE FOR SOLUTION FOR INFUSION USP, 300MG/50ML) | $37.2K | 1 |
| PACLI SPAL 300(PACLITAXEL CONCENTRATE FOR SOLUTION FOR INFUSION USP 300MG/50ML) | $37.2K | 1 |
| PALIT SPAL-P (Paclitaxel Protein bound particles for injectable suspension 100 mg)(ANTICANCER DRUG) (QTY: 2062 NOS) | $36.8K | 1 |
SP Accure Labs Private Limited exports 55 distinct Paclitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PACLI SPAL L 300 Paclitaxel ConcentrateforSolution for Infus with 3 shipments worth $104.3K.
How Does SP Accure Labs Private Limited Compare to Nearest Paclitaxel Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | GETWELL PHARMA INDIA PRIVATE LIMITED | $1.7M | 106 | 11 | $15.8K |
| 7 | ACCURE LABS PRIVATE LIMITED | $1.6M | 33 | 1 | $50.0K |
| 13 | SP ACCURE LABS PRIVATE LIMITED ★ | $1.3M | 66 | 9 | $19.0K |
| 15 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $1.1M | 70 | 14 | $16.1K |
| 11 | CIPLA LIMITED | $950.0K | 19 | 5 | $50.0K |
SP Accure Labs Private Limited ranks #13 among 319 Indian Paclitaxel exporters. Average shipment value of $19.0K compared to the market average of $192.6K. The closest competitors by value are GETWELL PHARMA INDIA PRIVATE LIMITED and ACCURE LABS PRIVATE LIMITED.
Which Indian Ports Ship Paclitaxel Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 830 | 16.8% |
| SAHAR AIR | 614 | 12.5% |
| DELHI AIR | 599 | 12.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 554 | 11.2% |
| HYDERABAD AIR | 186 | 3.8% |
| AHEMDABAD AIR | 183 | 3.7% |
| Bombay Air | 172 | 3.5% |
| HYDERABAD ACC (INHYD4) | 160 | 3.2% |
What Other Oncology Products Does SP Accure Labs Private Limited Export?
SP Accure Labs Private Limited also exports these oncology products. Each links to the detailed product page.
About SP Accure Labs Private Limited
SP Accure Labs Private Limited exports 14 products worth $3.5M. Beyond Paclitaxel, top products include Protein, Bortezomib, Pazopanib, Cyclophosphamide, Cisplatin. View the complete SP Accure Labs Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SP Accure Labs Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 69 individual customs records matching SP Accure Labs Private Limited exporting Paclitaxel, covering 55 formulations to 9 countries via 23 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 142+ countries, 959+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paclitaxel Export Data from SP Accure Labs Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SP Accure Labs Private Limited's Paclitaxel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SP Accure Labs Private Limited
Full Company Profile →
14 products · $3.5M total trade · 3 categories
Paclitaxel Stats
Company Overview
Top Products by SP Accure Labs Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SP Accure Labs Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paclitaxel. For current shipment-level data, contact TransData Nexus.